Apple’s “re -designed” blood control feature strikes Apple watches in the United States today

More than a year after the import ban forced the company to remove blood oxygen monitoring from some Apple Watch in the United States, Apple says it will provide a copy of the feature of the feature later today. In a publication on The newsroom websiteThe company says the feature will be published to the Apple Watch Series 9 and Series 10 series and watch Ultra 2 users through the Apple Watch and iPhone update. Once Apple starts to launch the program, you will need to update your devices to iOS 18.6.1 and Watchos 11.6.1 to reach the re -formulated feature. After the update, any oxygen data in the blood captured by Apple Watch will be calculated on your iPhone, with displaying the resulting data in the respiratory system from the health app.

Apple said: “There will be no effect on the previously purchased Apple Watch units that include the original Oxy Oxygen feature, nor for the Apple Watch units that have been purchased outside the United States,” Apple said.

Today’s update is another unexpected development in a long legal hostility from Apple with Masimo. In 2021, the medical devices maker Apples against applesClaiming that the technology giant has violated its intellectual properties related to oxygen monitoring technology. After a few years of legitimacy back and forth, the case reached her head when American International Trade Committee ITC supported in advance and found that Apple had violated Massimo patents. After former President Biden chose not to veto the decision, Apple was forced to do so Temporarily stop Apple Watch Series 9 and Ultra 2 sales. The company later started selling wearable devices again After the update Remove the violating oxygen monitoring feature. Apple now says she is able to present jobs again, with a slight modification, due to a modern American customs rule.